In nonhuman primates, simian varicella virus (SV V) causes a natural disease which is clinically similar to human varicella-zoster virus (VZV) infections. The SV V and VZV genomes are similar in size and structure and share extensive DNA homology. This report presents the complete DNA sequence of the SV V genome. SV V DNA is 124, 138 bp in size, 746 bp shorter than VZV DNA, and 40.4% G ϩ C. The viral genome includes a 104, 104-bp unique long component bracketed by 8-bp inverted repeat sequences and a short component composed of a 4904-bp unique short region bracketed by 7557-bp inverted repeat sequences. A total of 69 distinct SV V open reading frames (ORFs) were identified, including three that are duplicated within the inverted repeats of the short component. Each of the SV V ORFs shares extensive homology to a corresponding VZV gene. The only major difference between SV V and VZV DNA occurs at the leftward terminus. SV V lacks a VZV ORF 2 homolog. In addition, SV V encodes an 882-bp ORF A that is absent in VZV, but has homology to the SV V and VZV ORF 4. The results of this study confirm the relatedness of SV V and VZV and provide further support for simian varicella as a model to investigate VZV pathogenesis and latency.
INTRODUCTION

Varicella-zoster virus (VZV, Human herpesvirus 3)
causes varicella (chickenpox), a common disease of childhood. Following primary infection, VZV establishes latent infection in neural ganglia. Later in life, the virus may reactivate, resulting in herpes zoster (shingles). While VZV infections are often relatively benign, they may be severe, causing debilitating and life-threatening disease, especially in immunosuppressed individuals. Unfortunately, studies to investigate VZV pathogenesis and latency and to evaluate antiviral agents and vaccines are hampered because VZV does not cause disease in experimental animals.
Simian varicella virus (SVV, Cercopithecus herpesvirus 7) causes a natural varicella-like disease in nonhuman primates (Oakes and d'Offay, 1988) . Simian varicella epizootics occur sporadically in facilities housing monkeys. Similar to VZV, SVV establishes latent infection in the host (Mahalingam et al., 1991) and may reactivate to cause secondary disease. The antigenic and genetic relatedness between SVV and VZV Gray and Oakes, 1984; Pumphrey and Gray, 1992) and the clinical and pathogenic similarities between simian and human varicella make SVV infection of nonhuman primates a valuable animal model to investigate varicella pathogenesis and antiviral strategies (Soike, 1992) .
The SVV and VZV genomes are similar in size and structure and are colinear with respect to gene organization Clarke et al., 1992; Pumphrey and Gray, 1992) . The DNA sequence of the entire 124.8-kb VZV double-stranded DNA genome has been determined (Davison and Scott, 1986) . The VZV DNA includes a 19.9-kb short (S) component covalently linked to a 105.0-kb long component (L). The S component consists of a 5.2-kb unique short (US) sequence bracketed by 7.3-kb internal and terminal inverted repeat sequences (IRS and TRS) . Likewise, the L component includes 88-bp internal and terminal inverted repeat sequences (IRL and TRL), which bracket the 104.8-kb unique long (UL) component. Restriction endonuclease mapping and electron microscopic analysis of SVV DNA indicate that the SVV genome is approximately 121-125 kb in size and has a similar structure as VZV DNA Clarke et al., 1992) . DNA sequence analysis of the SVV US and IRS has confirmed the genetic relatedness of SVV and VZV (Fletcher and Gray, 1993; Gray et al., 1995) .
In this study, we present the complete DNA sequence of the SVV genome. The coding capacity and genetic content of SVV DNA is analyzed and compared to the VZV genome. The SVV DNA sequence provides a foundation for further investigation of the molecular basis of varicella pathogenesis and latency and for development of antiviral agents and vaccines.
RESULTS AND DISCUSSION
General features of SV V DNA: Size, structure, and guanine ϩ cytosine percentage (G ϩ C%)
The entire SVV genome sequence was determined by a directed sequencing approach utilizing overlapping SVV DNA BamHI and EcoRI RE fragments . The total sequence data included approximately 1 ϫ 10 6 nucleotides derived from both DNA strands. The results confirm that the SVV genome includes L and S components, each composed of a unique sequence (UL and US) bracketed by internal and terminal inverted repeat sequences (IRL/TRL and IRS/TRS) (Fig. 1) .
The SVV genome is 124, 138 bp in size, similar to the 121-125 kb size originally estimated by restriction endonuclease analysis and pulsed-field gel electrophoresis Clarke et al., 1992) . The SVV genome is 746 bp smaller than the VZV genome, making SVV DNA the smallest herpesvirus genome sequenced to date (Table 1) . Most of this size differential is attributed to the 104, 120-bp SVV L component which is 893 bp shorter than the VZV L component. The SVV UL component (104, 104 bp) is bracketed by an 8-bp inverted repeat sequence (GGCCGGGG) compared to the 88-bp VZV IRL and TRL.
The SVV and VZV S components are similar in size. The total length of the SVV S component (20,018 bp) is only 147 bp longer than the VZV S component. The SVV IRS/TRS is slightly expanded compared to the VZV IRS/ TRS (7557 vs 7319 bp), while the SVV US is slightly shorter in length than the VZV US (4904 vs 5232 bp).
The calculated size of SVV DNA does not take into account the possibility of unpaired nucleotides at the genome termini. The VZV and herpes simplex virus type 1 (HSV-1) genomes include a single unpaired nucleotide at each 3Ј terminus (Davison, 1984; Mocarski and Roizman, 1982) . The presence of unpaired terminal nucleotides facilitates circularization of the VZV and HSV-1 genomes during viral replication. Since circular SVV DNA is detected within infected cells, it is expected that the SVV genome also includes terminal unpaired nucleotides (Clarke et al., 1995) . Compared to the 46% G ϩ C content of VZV DNA, the SVV genome has an overall 40.4% G ϩ C content, similar to the 40.8% G ϩ C previously determined experimentally by buoyant density analysis (Clarke et al., 1992) . The SVV L component has a slightly lower G ϩ C content (38.3%) than the VZV DNA L component (44.3%). Similar to VZV DNA, the SVV DNA IRS and TRS have a relatively high G ϩ C content (65.0%), while the US has a low G ϩ C content (39.1%).
SVV gene map
The map locations of the predicted SVV open reading frames (ORFs) are shown in Fig. 1 and Table 2 . SVV ORFs were identified by methionine-initiated peptides of at least 70 amino acids and by codon usage. The analysis was facilitated by comparison to the previously published VZV gene map (Davison and Scott, 1986) . A total of 72 SVV ORFs were identified. This total includes 69 unique SVV genes, since three ORFs (69, 70, and 71) are duplicated within the IRS and TRS. Of these 69 ORFs, 53 (77%) terminate near a consensus polyadenylation site ( Fig. 1 , AATAAA or ATTAAA). Many of the SVV ORFs that lack a polyadenylation site are included among genes which have overlapping protein coding sequences. The overlapping ORFs were identified within three regions of the SVV genome, including map units 0. 27, 28) , map units 0.66-0.69 (ORFs 46, 47, 48, 49) , and map units 0.79-0.82 (ORFs 57, 58 and 59, 60). Overlapping VZV genes are also confined within these same general areas of the VZV genome (Davison and Scott, 1986) .
In general, the gene organization of the SVV and VZV genomes is remarkably similar. With only a single exception (described below), each of the SVV ORFs has a corresponding VZV homolog which shares amino acid identity ranging from 75.4% (ORF 31, glycoprotein B) to 27.3% (ORF 1). For reasons of consistency, each of the SVV ORFs is designated by a number corresponding to the number of the VZV homolog.
The left terminus of the SVV and VZV genomes includes the most notable differences in gene organization. First, SVV DNA does not include a homolog of the VZV ORF 2, a gene of unknown function. Second, the SVV genome encodes a gene, ORF A, which is not present in the VZV genome. The 879-bp SVV ORF A is a truncated homolog of ORF 4 with 42 and 49% amino acid identity to the SVV and VZV ORF 4, respectively. The VZV ORF 4 is a transcriptional activator of viral and cellular promoters (Perera et al., 1994) . The SVV left terminus also includes a 342-bp ORF B, located adjacent to ORF 1. The ORF B is homologous to the VZV ORF S/L, a recently identified gene of unknown function (Mahalingam et al., 2000; Kemble et al., 2000) . A detailed analysis of the SVV left terminus is reported elsewhere (Mahalingam et al., 2000) .
As with VZV and HSV-1, splicing of viral transcripts appears to be an infrequent event in SVV gene expression. However, splicing involving SVV ORFs 42 and 45 as protein coding exons is predicted (Fig. 1) based on analogy with VZV, HSV-1, and Epstein Barr virus (EBV) gene homologs (Costa et al., 1984) . The intron includes complementary sequences to the opposite-strand ORFs 43 and 44. The HSV-1 homolog (UL 15) of the SVV and VZV 42/45 protein is a putative viral terminase and is one of the six HSV-1 products required for DNA cleavage and packaging (Yu and Weller, 1998) . The significance of the conservation of the splicing of this gene in alpha-and gammaherpesviruses is not understood. Evidence for RNA splicing was recently reported for the VZV strain Oka ORF S/L transcript (Kemble et al., 2000) . A 130 nt intron was identified within the 3Ј untranslated region of the ORF S/L mRNA. DNA sequence analysis suggests that the homologous SVV ORF B transcript also includes putative donor and acceptor splice sites and a 175 nucleotide intron (nt 2698-2873) within the 3Ј untranslated region.
Repetitive DNA Tandem direct repeat sequences are commonly detected within the genomes of herpesviruses (Davison and Scott, 1986; McGeoch et al., 1988; Telford et al., 1992) . Four such reiterations were identified within the SVV genome and are denoted as R1, R2, R3, and R4 (Fig.  1, Table 3 ). Three of these correspond to reiterations in similar locations within the VZV genome.
The SVV DNA R1 reiteration occurs in a noncoding region between ORFs 7 and 8. R1 consists of an A ϩ T rich (54%) 37 mer, which is tandemly repeated three times. No such reiteration is found between ORFs 7 and 8 in the VZV genome. In contrast, the VZV R1, located within the coding region of ORF 11, is a 305-bp sequence including 15 or 18 bp direct repeat elements (Davison and Scott, 1986) . The SVV genome does not include a corresponding repeat region within ORF 11.
The SVV R2, similar to the VZV R2, is located within the coding region of ORF 14 (glycoprotein C). The 179-bp SVV R2 includes an 83-bp G ϩ C rich (66%) sequence which is repeated twice, but is interrupted with a 13-bp intervening sequence. The VZV R2 is a 42-bp sequence which is repeated seven times in the VZV Dumas strain (Davison and Scott, 1986) .
The SVV and VZV R3 elements are located within the coding frame of ORF 22. This is the longest (249 bp) and most complex of the SVV reiterations and consists of eight 12-bp repeats and seventeen 9-bp repeats. The VZV R3 is a 9-bp sequence which is estimated to be repeated as many as 100 times or more (Davison and Scott, 1986) . However, sequence analysis of this highly (Fig. 1) . The SVV R4 is a 119-bp G ϩ C rich (81%) element consisting of a 16-bp sequence which is tandemly repeated seven times plus a 7-bp partial repeat. The SVV R4 shares homology to the VZV R4 that consists of a 27-bp element which is repeated four times.
The VZV genome has an additional R5 direct repeat sequence located within the 1400-bp noncoding region between ORFs 60 and 61 (Davison and Scott, 1986; Hondo and Yogo, 1988) . The VZV R5 consists of an 88-bp element and an adjacent 24-bp element which together constitute a repeat unit whose copy number varies from one to three in various VZV strains. The SVV genome also includes a long noncoding region (1180 bp) between ORFs 60 and 61. Repeat elements were not identified within this region of the SVV genome. However, since repeat elements may vary among SVV isolates, further analysis of additional SVV isolates may reveal a R5 element.
The VZV R1, R2, R3, R4, and R5 are variable in size among VZV isolates, causing some diversity in the total size of VZV DNA ranging from 124 to 126 kb. For example, the 42-bp R2 sequence is repeated seven times in VZV strain Dumas, but only three times in VZV strain Oka (Davison and Scott, 1986; Kinchington et al., 1986) . In contrast, analysis of the genomes of four epidemiologically distinct SV V isolates indicates that the SV V 83-bp R2 does not vary in number and is only repeated twice (data not shown). The SV V R1, R3, and R4 have not yet been analyzed for diversity among SV V isolates.
The function, if any, of these tandem reiterations in SVV DNA and the genomes of other herpesvirus genomes is unknown. They have been speculated to be "parasitic" sequences which have been incorporated, possibly by recombination, into the viral genomes in locations where they do not cause a deleterious effect and thus are conserved (Davison and Scott, 1986) . Davison and Scott (1986) . d Based on known VZV function or function of HSV-1 homolog (Arvin, 1996; Harper et al., 1998; Subak-Sharpe and Dargan, 1998) . e Predicted spliced gene including ORF 42 and 45 exons.
Significance of the SVV DNA sequence
Genetic analysis of viral genomes provides an understanding of the evolutionary relationships among herpesviruses (McGeoch et al., 1995) . The striking similarity in genetic content of the SV V and VZV genomes indicates a common evolutionary origin and divergence from a common ancestral varicella virus. Further phylogenetic comparison of the SV V and VZV DNA sequences will permit the derivation of a time scale for the divergence of SV V and VZV and provide an excellent model system for investigation of alphaherpesvirus evolution.
The genetic relatedness of SVV and VZV is correlated to similarities in the biological properties of the viruses, including viral morphology, replication, and pathogenesis. However, VZV replicates most efficiently in cells of human origin and causes disease in humans, but not in monkeys. Conversely, SVV replicates optimally in cells of nonhuman primate origin and is not associated with disease in humans. Genetic analysis of the differences between the SVV and VZV genomes may reveal the molecular basis for the species specificity of these viruses.
The complete DNA sequence of the SVV genome provides a blueprint for investigating the function of SVV genes and their roles in viral replication, pathogenesis, and latency. The information will be important for the development of diagnostic assays and antiviral strategies to control simian varicella epizootics which occur in facilities housing nonhuman primates. In addition, this study provides further support for simian varicella as a model to investigate the molecular basis of VZV pathogenesis and the development and evaluation of VZV antiviral agents and vaccines.
MATERIALS AND METHODS
Virus culture and isolation of SVV DNA
The Delta herpesvirus strain of SVV was originally isolated from an infected patas monkey (Erythrocebus patas) at the Tulane Regional Primate Center in Covington, LA (Ayres, 1971) . SVV was propagated in African green monkey kidney (BSC-1) cells in Eagle's minimal essential medium (EMEM) supplemented with penicillin (5000 U/ml), streptomycin (5000 U/ml), and 5% newborn calf serum. The virus was passaged by cocultivation of infected and uninfected cells at a ratio of 1:4, respectively. SVV DNA was purified from viral nucleocapsids derived from infected BSC-1 cells .
DNA sequencing
SVV DNA BamHI and EcoRI restriction endonuclease (RE) fragments making up the entire viral genome were cloned into plasmid vectors . The Genome Priming System (New England Biolabs, Inc.) was used to generate subclones and DNA sequencing templates with random interspersed primer binding sites. Both strands of each RE fragment were sequenced. DNA between adjacent nonoverlapping RE fragments was amplified by PCR using SVV genomic DNA as template and oligonucleotide primers which were synthesized based on the DNA sequence at the RE fragment termini. Dideoxy chain termination sequencing reactions were performed using oligonucleotide primers, AmpliTaq DNA polymerase, and the ABI Prism BigDye or dRhodamine terminator cycle sequencing ready reaction kit (PerkinElmer Applied Biosystems). Reaction products were analyzed using a Perkin-Elmer Applied Biosystems Prism 377 DNA fluorescence sequencer.
The DNA sequence of the left and right termini of the SVV genome was previously determined (Clarke et al., 1995; Mahalingam et al., 2000) . Briefly, SVV DNA containing the left and right termini was amplified by PCR using primers located near the ends of the viral genome. Sequence analysis of the resulting PCR product along with sequence analysis of the SVV IRL/IRS junction (Gray et al., 1995) was used to define the DNA sequence of the ends of the SVV genome.
DNA sequence analysis
The DNA sequence data were assembled and analyzed using the Sequence Analysis Software Package of the Genetics Computer Group (GCG), University of Wisconsin . Overlapping nucleotide sequences of both DNA strands were assembled into the final sequence using the Gel Assemble program based on the method of Staden (Staden, 1980) . Protein coding regions were determined by using the Frames and Testcode programs (Fickett, 1982) . The Codon Preference and Codon Frequency programs were used to analyze codon usage and confirm ORFs (Gribskov et al., 1984) . Amino acid sequence homologies were determined using the Bestfit program, which employs the local homology algorithm of Smith and Waterman (1981) . The Motifs program was used to search for sequence motifs within protein sequences for patterns defined in the PROSITE Dictionary of Protein Sites and Patterns (Bairoch, 1991) . The SVV DNA sequence is available in the GenBank data library under the Accession No. AF275348.
